《美股業績》晶片商安森美(ON.US)季收預期勝預期 推動美晶片股上揚
美國汽車及工業晶片生產商安森美(On Semiconductor)(ON.US)公布首季業績。季度純利按年跌13%至4.62億美元,每股季度攤薄純利1.03美元,經調整後為1.19美元。季度收入按年升不足1%至19.6億美元。
公司預期現季度收入介乎19.75億至20.75億美元,按預測中位數計算為較去年同期減少3%。勝於市場預期的下跌7%。
安森美股價昨日(1日)升8.9%報78.33美元。亦推升其他晶片股股價。費城半導體指數升0.8%,晶片巨擘Nvidia(NVDA.US)更升4.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.